» Articles » PMID: 20174833

Reactive Oxygen Species-quenching and Anti-apoptotic Effect of Polaprezinc on Indomethacin-induced Small Intestinal Epithelial Cell Injury

Abstract

Background: To protect the small intestine from mucosal injury induced by nonsteroidal anti-inflammatory drugs is one of the critical issues in the field of gastroenterology. Polaprezinc (PZ), a gastric muco-protecting agent, has been widely used for the treatment of gastric ulcer and gastritis for its unique effects, such as its strong reactive oxygen species (ROS)-quenching effect. The aim of this study was to clarify the mechanism by which indomethacin-induced small intestinal mucosal injury occurs, by using a rat intestinal epithelial cell line (RIE-1). In addition, the protective role of PZ and the possible mechanism of its effect on indomethacin-induced small intestinal injury were investigated.

Methods: Cell death was evaluated by methyl thiazolyl tetrazolium (MTT) assay and a double-staining method with Hoechst33342 dye and propidium iodide. Indomethacin-induced ROS production was evaluated by detecting the oxidation of a redox-sensitive fluorogenic probe, RedoxSensor, and the oxidation of cysteine residues of proteins (protein S oxidation). The activation of cytochrome c, smac/DIABLO, and caspase-3 was assessed by western blotting. In some experiments, PZ or its components, L: -carnosine and zinc, were used.

Results: We found that indomethacin caused apoptosis in RIE-1 cells in a dose- and time-dependent manner. Indomethacin also induced ROS production and an increase in the protein S oxidation of RIE-1. Pretreatment of RIE-1 with PZ or zinc sulfate, but not L: -carnosine, significantly reduced the indomethacin-induced apoptosis. PZ prevented ROS production and the increase in protein S-oxidation. PZ inhibited indomethacin-induced cytochrome c and smac/DIABLO release and subsequent caspase-3 activation.

Conclusions: The protective effect of PZ on indomethacin-induced small intestinal injury may be dependent on its ROS-quenching effect.

Citing Articles

The association between serum zinc level and clinical features in patients with inflammatory bowel disease.

Omatsu T, Takagi T, Yasuda T, Nakahata Y, Hayashi S, Mukai R J Clin Biochem Nutr. 2025; 76(1):50-58.

PMID: 39896166 PMC: 11782769. DOI: 10.3164/jcbn.24-64.


A dual role of lysophosphatidic acid type 2 receptor (LPAR2) in nonsteroidal anti-inflammatory drug-induced mouse enteropathy.

Hutka B, Varallyay A, Laszlo S, Toth A, Scheich B, Paku S Acta Pharmacol Sin. 2023; 45(2):339-353.

PMID: 37816857 PMC: 10789874. DOI: 10.1038/s41401-023-01175-7.


Therapeutic Effect of Polaprezinc on Reflux Esophagitis in the Rat Model.

Xie W, An L, Liu Z, Wang X, Fu X, Ma J Dig Dis Sci. 2023; 68(8):3283-3292.

PMID: 37335414 DOI: 10.1007/s10620-023-07990-6.


Ameliorating Role of Hydrogen-Rich Water Against NSAID-Induced Enteropathy via Reduction of ROS and Production of Short-Chain Fatty Acids.

Akita Y, Higashiyama M, Kurihara C, Ito S, Nishii S, Mizoguchi A Dig Dis Sci. 2022; 68(5):1824-1834.

PMID: 36478314 PMC: 9734488. DOI: 10.1007/s10620-022-07781-5.


Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Mahmoud A, Abuelazm M, Ahmed A, Abdalshafy H, Abdelazeem B, Brasic J Nutrients. 2022; 14(19).

PMID: 36235778 PMC: 9573391. DOI: 10.3390/nu14194126.


References
1.
Naito Y, Yoshikawa T, Yoshida N, Kondo M . Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury. Dig Dis Sci. 1998; 43(9 Suppl):30S-34S. View

2.
Kuroda M, Yoshida N, Ichikawa H, Takagi T, Okuda T, Naito Y . Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med. 2005; 17(1):89-93. View

3.
Stowe D, Camara A . Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal. 2009; 11(6):1373-414. PMC: 2842133. DOI: 10.1089/ars.2008.2331. View

4.
Maiden L, Thjodleifsson B, Seigal A, Bjarnason I, Scott D, Birgisson S . Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol. 2007; 5(9):1040-5. DOI: 10.1016/j.cgh.2007.04.031. View

5.
Wallace J, Keenan C, Granger D . Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol. 1990; 259(3 Pt 1):G462-7. DOI: 10.1152/ajpgi.1990.259.3.G462. View